Your browser doesn't support javascript.
loading
Corrigendum: Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation.
Tang, Guo-Qing; Tang, Yalan; Dhamnaskar, Ketki; Hoarty, Michelle D; Vyasamneni, Rohit; Vadysirisack, Douangsone D; Ma, Zhong; Zhu, Nanqun; Wang, Jian-Guo; Bu, Charlie; Cong, Bestine; Palmer, Elizabeth; Duda, Petra W; Sayegh, Camil; Ricardo, Alonso.
Afiliación
  • Tang GQ; UCB Pharma, Cambridge, MA, United States.
  • Tang Y; UCB Pharma, Cambridge, MA, United States.
  • Dhamnaskar K; Ra Pharmaceuticals, Cambridge, MA, United States.
  • Hoarty MD; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States.
  • Vyasamneni R; Ra Pharmaceuticals, Cambridge, MA, United States.
  • Vadysirisack DD; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States.
  • Ma Z; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States.
  • Zhu N; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States.
  • Wang JG; UCB Pharma, Cambridge, MA, United States.
  • Bu C; UCB Pharma, Cambridge, MA, United States.
  • Cong B; UCB Pharma, Cambridge, MA, United States.
  • Palmer E; UCB Pharma, Cambridge, MA, United States.
  • Duda PW; UCB Pharma, Cambridge, MA, United States.
  • Sayegh C; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States.
  • Ricardo A; Ra Pharmaceuticals, Cambridge, MA, United States.
Front Immunol ; 14: 1282155, 2023.
Article en En | MEDLINE | ID: mdl-37818356
ABSTRACT
[This corrects the article DOI 10.3389/fimmu.2023.1213920.].
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article